Axsome Therapeutics, Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for AXSM, updated each market day.
AXSM AI Sentiment
AI sees no strong directional signal for Axsome Therapeutics, Inc stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Axsome Therapeutics, Inc
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Sector
Exchange
Market Cap
$9,151,323,402
Cap Tier
Employees
925
Headquarters
NEW YORK, NY
Listed Since
Nov. 19, 2015
Website
AXSM Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
AXSM Volatility
Axsome Therapeutics, Inc has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
